Boardroom Alpha
Boardroom Alpha
LMT · Additional Proxy Materials (DEFA14A) · Filed March 26, 2026

Lockheed Martin Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 26, 2026
Ticker
LMT
Accession
0000936468-26-000006
Boardroom Alpha · Filing insights

Consult the filing for more details.

About Lockheed Martin Corp
Market cap
$118.4B
1Y TSR
+12.7%
3Y TSR
+7.1%
Board grade
C+
Sector
Industrials
CEO
James D Taiclet Jr
Last annual meeting: May 12, 2026 · View full Lockheed Martin Corp profile →
Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )

Filed by the Registrant
Filed by a Party other than the Registrant
Check the appropriate box:
 Preliminary Proxy Statement
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
 Definitive Additional Materials
Soliciting Material under § 240.14a-12

lm-logo_blue2.jpg

Lockheed Martin Corporation

(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check all boxes that apply):
 No fee required
Fee paid previously with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11




a048woc_lockheedxnoticex03b.jpg



a048woc_lockheedxnoticex03c.jpg





oconnoremployeeemla.jpg




Email to Employee Plan Participants (to be sent 03/31/2026)

Email subject:
Lockheed Martin 2026 Annual Meeting – Please Vote Your Shares

Important Notice Regarding the Availability of Proxy Materials for the Lockheed Martin Corporation Stockholder Meeting to be Held on May 12, 2026.

You are receiving this email because you own shares of Lockheed Martin Corporation in your Lockheed Martin Corporation savings plan.

You may now conveniently access Lockheed Martin’s annual report and proxy statement and vote online for Lockheed Martin’s Annual Stockholder Meeting at www.investorvote.com/LMT. We encourage you to access and review all of the important information contained in the proxy materials before voting.

How to Vote:

Online: Go to: www.investorvote.com/LMT, enter the Proxy Login Control Number below (without any spaces) and follow the on-screen instructions.

By Phone: Call 1-800-652-VOTE (8683) or 1-781-575-2300 and following the prompts (you must have your Proxy Login Control Number below available).

Proxy Login Control Number: [[SingleControlNumber]]

Voting deadline: Thursday, May 7, 2026, at 11:59 p.m. Eastern Daylight Time

To obtain a hard copy of the proxy materials (free of charge) call 1-866-641-4276.

Please note: you may receive multiple proxy packages and voting instructions (electronically and/or by mail). These materials may not be duplicates as you may hold shares of Lockheed Martin stock in multiple accounts. Please be sure to vote all of your shares in each of your accounts in accordance with the directions on the proxy card(s) and/or voting instruction form(s) you receive.

Your vote matters – please cast your vote today.

Computershare Trust Company, N.A.
Independent Registrar and Transfer Agent for Lockheed Martin Corporation



computershareregisteredemla.jpg

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Lockheed Martin Corp (LMT)

Reference

Frequently asked questions

When did Lockheed Martin Corp file this DEFA14A?
Lockheed Martin Corp (LMT) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 26, 2026. The accession number assigned by EDGAR is 0000936468-26-000006.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Consult the filing for more details. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Lockheed Martin Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Lockheed Martin Corp has filed under CIK 936468, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer